(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202303 | 202203 | % Var | 202303 | 202203 | % Var | 202303 | 202203 | % Var | |
| Sales | 10545.80 | 11270.90 | -6.43 | 34432.20 | 33404.20 | 3.08 | 34432.20 | 33404.20 | 3.08 |
| Other Income | 628.80 | 752.90 | -16.48 | 3410.70 | 2247.90 | 51.73 | 3410.70 | 2247.90 | 51.73 |
| PBIDT | 1524.30 | 2575.40 | -40.81 | 4386.00 | 7000.70 | -37.35 | 4386.00 | 7000.70 | -37.35 |
| Interest | 337.80 | 196.40 | 72.00 | 1158.70 | 572.90 | 102.25 | 1158.70 | 572.90 | 102.25 |
| PBDT | 1186.50 | 2379.00 | -50.13 | 3157.70 | 6277.00 | -49.69 | 3157.70 | 6277.00 | -49.69 |
| Depreciation | 530.10 | 513.80 | 3.17 | 1920.80 | 1653.70 | 16.15 | 1920.80 | 1653.70 | 16.15 |
| PBT | 656.40 | 1865.20 | -64.81 | 1236.90 | 4623.30 | -73.25 | 1236.90 | 4623.30 | -73.25 |
| TAX | 239.40 | 350.80 | -31.76 | 541.90 | 947.90 | -42.83 | 541.90 | 947.90 | -42.83 |
| Deferred Tax | 2.80 | -177.20 | -101.58 | 154.20 | -160.30 | -196.19 | 154.20 | -160.30 | -196.19 |
| PAT | 417.00 | 1514.40 | -72.46 | 695.00 | 3675.40 | -81.09 | 695.00 | 3675.40 | -81.09 |
| Equity | 11933.20 | 11859.10 | 0.62 | 11933.20 | 11859.10 | 0.62 | 11933.20 | 11859.10 | 0.62 |
| PBIDTM(%) | 14.45 | 22.85 | -36.74 | 12.74 | 20.96 | -39.22 | 12.74 | 20.96 | -39.22 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: